IMRT offers better outcome for head/neck cancer patients

Patients treated with intensity-modulated radiation therapy (IMRT) for head and neck cancer reported increasingly better quality of life after treatment than patients receiving other forms of radiotherapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.

At a January 27 press conference, Dr. Allen Chen, a radiation oncologist at the University of California, Davis, reported the findings of a quality-of-life questionnaire that was prospectively administered to 155 patients. Eighty-four patients (54%) were treated using IMRT with inclusion of the low neck in an extended field. Seventy-one (46%) patients received 3D conformal radiotherapy (3D-CRT) using opposed lateral fields matched to a low anterior neck field.

The purpose of the study was to evaluate the effect of newer radiation therapy treatments on patients' long-term quality of life, Chen said. Patients were surveyed with the University of Washington Quality of Life questionnaire every six months following treatment during a period of more than three years.

IMRT patients gave better overall rankings of their quality of life, Chen reported. At one year post-treatment, 51% of IMRT patients ranked their quality of life as "very good" or "outstanding," compared with 41% for the other group. Furthermore, two years after treatment, the percentage for the IMRT patients increased to 73%, compared with 49% for the 3D-CRT group.

Also, at their last follow-up exam, 80% of the IMRT patients reported that their health-related quality of life was "much better" or "somewhat better" than in the month before they were diagnosed with cancer. Only 61% of the 3D-CRT group gave the same response.

Interestingly, salivary function -- i.e., dry mouth -- was the only individual category in which patients reported a statistically significant difference in quality of life. IMRT patients had a median score of 70.5 for their satisfaction with saliva production, compared with 50.6 for 3D-CRT patients 12 months after treatment. Two years following treatment, the scores were 77.3 and 53.0, respectively, for the two groups.

"We first confirmed what has been known for a long time: that IMRT can improve salivary function," Chen said. "Historically, this is important because chronic dry mouth has been one of the most common side effects. It's not only a daily nuisance, but it's also a chronic reminder of one's cancer experience many years out from treatment."

The patients will continue to be followed indefinitely to determine if the advantages of IMRT are sustainable over time.

Page 1 of 461
Next Page